[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL378334A1 - Kompozycja podłoża hodowlanego, sposób hodowli i sposób produkcji mioblastów, oraz ich zastosowanie - Google Patents

Kompozycja podłoża hodowlanego, sposób hodowli i sposób produkcji mioblastów, oraz ich zastosowanie

Info

Publication number
PL378334A1
PL378334A1 PL378334A PL37833403A PL378334A1 PL 378334 A1 PL378334 A1 PL 378334A1 PL 378334 A PL378334 A PL 378334A PL 37833403 A PL37833403 A PL 37833403A PL 378334 A1 PL378334 A1 PL 378334A1
Authority
PL
Poland
Prior art keywords
culture
medium composition
culture medium
myoblasts obtained
culture method
Prior art date
Application number
PL378334A
Other languages
English (en)
Inventor
Christian Pinset
Original Assignee
Celogos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celogos filed Critical Celogos
Publication of PL378334A1 publication Critical patent/PL378334A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL378334A 2002-12-13 2003-12-12 Kompozycja podłoża hodowlanego, sposób hodowli i sposób produkcji mioblastów, oraz ich zastosowanie PL378334A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0215827 2002-12-13

Publications (1)

Publication Number Publication Date
PL378334A1 true PL378334A1 (pl) 2006-03-20

Family

ID=32524649

Family Applications (1)

Application Number Title Priority Date Filing Date
PL378334A PL378334A1 (pl) 2002-12-13 2003-12-12 Kompozycja podłoża hodowlanego, sposób hodowli i sposób produkcji mioblastów, oraz ich zastosowanie

Country Status (16)

Country Link
US (1) US20060258003A1 (pl)
EP (1) EP1572988A1 (pl)
JP (1) JP2006509516A (pl)
KR (1) KR20050088118A (pl)
CN (1) CN1723277A (pl)
AU (1) AU2003300585A1 (pl)
BR (1) BR0316757A (pl)
CA (1) CA2509642A1 (pl)
IL (1) IL169115A0 (pl)
MX (1) MXPA05006350A (pl)
NO (1) NO20053357L (pl)
NZ (1) NZ540723A (pl)
PL (1) PL378334A1 (pl)
RU (1) RU2005122030A (pl)
WO (1) WO2004055174A1 (pl)
ZA (1) ZA200505125B (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007144467A1 (en) * 2006-06-12 2007-12-21 Zora Biosciences Oy Diagnostic method for myopathy
US20100092432A1 (en) * 2006-08-08 2010-04-15 Takenori Ozaki Cell preparation containing multipotential stem cells originating in fat tissue
EP1900810A1 (fr) * 2006-09-15 2008-03-19 Celogos Methode d'extraction et de selection de cellules
US20080208164A1 (en) 2007-02-28 2008-08-28 Innovacell Biotechnologie Gmbh Methods for the treatment of anal incontinence
US20090042296A1 (en) * 2007-03-16 2009-02-12 Marie Callahan Transfection ready eukaryotic cells
US20080311219A1 (en) * 2007-06-15 2008-12-18 Anna Gosiewska Tissue Fragment Compositions for the Treatment of Incontinence
CN101386836B (zh) * 2007-09-12 2010-11-24 北京清大天一科技有限公司 动物细胞培养基干粉组合物、培养基组合物及其制备方法
ES2360782B1 (es) 2009-07-28 2012-03-12 Grifols, S.A. Medios para cultivo de células de mamíferos que comprenden sobrenadante de etapas del fraccionamiento de Cohn y uso de los mismos.
EP2397851B1 (fr) 2010-06-21 2015-01-07 Centre d'Etude des Cellules Souches Méthode de sélection des modulateurs de la synthèse de mévalonate en utilisant des cellules dérivées de cellules pluripotentes humaines
JP2012029623A (ja) * 2010-07-30 2012-02-16 Bio Link Inc 細胞分離用酵素溶液及び細胞分離方法、並びに膵島分離方法
WO2014044867A1 (en) * 2012-09-24 2014-03-27 Innovacell Biotechnologie Ag Potency assay for skeletal muscle derived cells
EP3081223B1 (en) * 2013-12-12 2020-02-19 Samsung Life Public Welfare Foundation Method for promoting generation of stem cell-derived exosome by using thrombin
US10711248B2 (en) 2013-12-18 2020-07-14 Cytoo Device and method for standardizing myoblast differentiation into myotubes
RU2576842C2 (ru) * 2014-02-28 2016-03-10 Общество С Ограниченной Ответственностью "Витацел" Способ получения миобластов, использование биоптата десны, препарат миобластов для лечения патологий мышечной ткани и способ его получения
EP3120857B1 (en) 2014-03-18 2021-02-17 Samsung Life Public Welfare Foundation Compositions for use in treating inflammatory brain disease comprising stem-cell-derived exosomes as an active ingredient
KR102434588B1 (ko) 2014-06-18 2022-08-22 메디뮨 엘엘씨 N-아세틸시스테인을 포함하는 세포 배양 방법 및 배지
KR101960497B1 (ko) * 2016-05-09 2019-03-21 고려대학교 산학협력단 소변 유래 세포 배양용 배지 조성물
EP3728560A4 (en) * 2017-07-15 2021-04-14 Aleph Farms Ltd. MEAT COMPOSITIONS IN CULTURE
US20220104481A1 (en) * 2019-02-13 2022-04-07 Tigenix, S.A.U. Cryopreservation of stem cells
CN112592890A (zh) * 2020-12-17 2021-04-02 江南大学 一种促进肌肉干细胞增殖的方法
US20240182859A1 (en) * 2021-03-29 2024-06-06 Hyupsung University Industry-Academic Cooperation Foundation Medium composition for culturing muscle stem cell comprising curcumin longa, glysin, or insulin for proliferation of muscle stem cell
CN114752590B (zh) * 2022-01-14 2023-09-08 江南大学 一种高效且经济的猪肌肉干细胞的分离方法及其应用
CN117625519A (zh) * 2022-08-12 2024-03-01 江南大学 促肌肉干细胞体外存活和增殖的无胎牛血清培养基及其应用
CN117925509B (zh) * 2024-03-25 2024-06-11 山东三链医疗科技有限公司 一种细胞培养替代血清培养液及方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7984498A (en) * 1997-06-25 1999-01-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Serum-free cell growth medium

Also Published As

Publication number Publication date
CA2509642A1 (fr) 2004-07-01
BR0316757A (pt) 2005-10-25
KR20050088118A (ko) 2005-09-01
ZA200505125B (en) 2006-03-29
NZ540723A (en) 2008-04-30
NO20053357D0 (no) 2005-07-11
CN1723277A (zh) 2006-01-18
JP2006509516A (ja) 2006-03-23
EP1572988A1 (fr) 2005-09-14
NO20053357L (no) 2005-07-11
WO2004055174A1 (fr) 2004-07-01
AU2003300585A1 (en) 2004-07-09
MXPA05006350A (es) 2006-02-08
IL169115A0 (en) 2007-07-04
RU2005122030A (ru) 2005-12-20
US20060258003A1 (en) 2006-11-16

Similar Documents

Publication Publication Date Title
IL169115A0 (en) Culture medium composition culture method, and myoblasts obtained, and their uses
AU2003251858A1 (en) Microbubble compositions, and methods for preparing and using same
AU2003274906A1 (en) Double stranded rna structures and constructs, and methods for generating and using the same
MX256798B (es) Dispersiones de polimeros en medio organico y composiciones que las comprenden.
AU2002234076A1 (en) Construction composition, structure, and method
AU2003225947A1 (en) Amylases, nucleic acids encoding them and methods for making and using them
AU2003246159A1 (en) Nobonene-ester based addition polymer and method for preparing the same
AU2001280149A1 (en) Stem cell culture medium and culture method by using the same
AU2003256710A1 (en) Auto-stimulating cells and method for making and using the same
AU2002336930A1 (en) Method for producing isolated cell cultures, culture medium for cultivating cell cultures and cell culture
AU2003285906A1 (en) Amylases, nucleic acids encoding them and methods for making and using them
AU2003303735A1 (en) Oligomer silasesquioxanes, method for the production thereof, and use of the same
AU2003236118A1 (en) An antispastic, analgetic pharmaceutical composition and the preparation method thereof as well as the quality control technique therefor
AU2003247449A1 (en) Nano-ceramics and method thereof
AU2003265040A1 (en) Drill rod and method in order to manufacture the same
AU2003237332A1 (en) Anti-relp fusion antibodies, compositions, methods and uses
AU2003250545A1 (en) Recording apparatus, recording method and recording medium
AU2001234616A1 (en) Vaccine composition, process and methods
EP1416947A4 (en) FERMENTATION MEDIUM AND METHOD
AU4771600A (en) Cells, culture methods and their uses
AU2001277742A1 (en) Solid culture medium and method for preparing the same
AU2003267993A1 (en) Monooxygenases, nucleic acids encoding them and methods for making and using them
AU2003266402A1 (en) Medium containing water with increased viscosity, method for production and use thereof
AU2003302001A1 (en) Ventilator method, ventilator and memory medium
GB0305089D0 (en) Composition, use and process

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)